- Home
- HCM vs NWBI Comparison
HCM vs NWBI Comparison
Compare HCM & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCM | NWBI |
|---|---|---|
| Founded | 2000 | 1896 |
| Country | Hong Kong | United States |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | HCM | NWBI |
|---|---|---|
| Price | $13.18 | $13.83 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $13.75 | ★ $14.50 |
| AVG Volume (30 Days) | 28.0K | ★ 1.0M |
| Earning Date | 03-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 5.82% |
| EPS Growth | N/A | ★ 16.46 |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | N/A |
| Revenue This Year | $20.60 | $6.29 |
| Revenue Next Year | $15.62 | $5.06 |
| P/E Ratio | ★ $5.49 | $15.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.82 | $11.25 |
| 52 Week High | $19.50 | $14.26 |
Technical Indicators
Market Signals| Indicator | HCM | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 59.87 |
| Support Level | $13.08 | $11.87 |
| Resistance Level | $15.59 | N/A |
| Average True Range (ATR) | 0.44 | 0.29 |
| MACD | -0.21 | 0.03 |
| Stochastic Oscillator | 13.68 | 61.90 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.